Evolent Health Inc Class A Com (EVH) 22.76 $EVH
Post# of 273318
Posted On: 09/26/2016 5:05:11 AM
Evolent Health Inc Class A Com (EVH) 22.76 $EVH
Business Talent Group Closes Series B Funding led by NextEquity Partners to Accelerate Firm's Leadership in the Fast-Growing Market for Independent Professionals
PR Newswire - Mon Sep 12, 7:00AM CDT
Business Talent Group (BTG), the leading platform for top independent consultants and executives doing project-based work, announced today that it has closed an $8 million Series B funding round led by NextEquity Partners. The round also includes participation from David and Katherine Bradley through the Bradley Family Trust; Ted Meisel, the former CEO of Overture and co-founder of AVIA Health Innovation; and numerous existing investors. NextEquity Managing Director Adam Hopkins will join BTG's board as will Frank Williams, CEO of Evolent Health and former CEO and Chairman of The Advisory Board Company. Ted Meisel and NextEquity Principal Rami Reyes, will join as board observers.
EVH: 22.76 (-0.04)
Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
PR Newswire - Thu Sep 08, 8:59PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health"
, today announced the pricing of a secondary public offering of 7,500,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The shares of Class A common stock are being sold to the public at a price of $22.50 per share. The offering was upsized from the previously announced offering size of 7,000,000 shares of Class A common stock. The underwriters have a 30-day option period to purchase up to 1,125,000 additional shares of Class A common stock from the Investor Stockholders. The offering is expected to close on September 14, 2016, subject to customary closing conditions.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)
Evolent Health, Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PR Newswire - Tue Sep 06, 3:01PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health", today announced the launch of an underwritten secondary public offering of 7,000,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The underwriters have a 30-day option period to purchase up to 1,050,000 additional shares of Class A common stock from the Investor Stockholders.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)
Evolent Health Partners with St. Luke's Health Partners to Enhance Care Delivery in Idaho
PR Newswire - Thu Aug 04, 3:20PM CDT
Evolent Health, Inc (NYSE: EVH), and St. Luke's Health Partners announced today that they have entered into a definitive agreement for a multi-year operating partnership. The collaboration between the two organizations will guide the development and execution of a value-based care strategy for improving the health of patients across the care delivery network of St. Luke's Health System, the largest locally-owned health system in the state of Idaho.
EVH: 22.76 (-0.04)
Evolent Health Announces Second Quarter 2016 Results
PR Newswire - Thu Aug 04, 3:19PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended June 30, 2016.
EVH: 22.76 (-0.04)
Evolent Health to Participate in Upcoming Investor Conferences
PR Newswire - Thu Jun 02, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, Seth Blackley, President and Co-Founder, Nicky McGrane, CFO, and Steve Wigginton, Chief Development Officer, will participate in upcoming investor conferences.
EVH: 22.76 (-0.04)
Chasm Partners Places New CEO for Remedy Partners
PRWeb - Thu May 26, 3:06AM CDT
Chasm Partners, a leading retained search firm focused exclusively on health technology and services, announced today the placement of Carolyn Magill as the new CEO of its client, Remedy Partners. Chasm Partners was selected earlier this year to lead the CEO search for Remedy Partners.
EVH: 22.76 (-0.04)
Evolent Health to Host Investor and Analyst Day on May 25, 2016
PR Newswire - Fri May 20, 8:42AM CDT
Evolent Health, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, will host its first Investor and Analyst Day on Wednesday, May 25, 2016 at its headquarters in Arlington, VA.
EVH: 22.76 (-0.04)
Evolent (EVH) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:14AM CDT
Evolent (EVH) reported loss of 24 cents per share, wider than the Zacks Consensus Estimate of a loss of 19 cents.
EVH: 22.76 (-0.04), MDSO: 56.51 (-0.08), QSII: 11.49 (unch), ATHN: 123.83 (-0.79)
Evolent Health Partners with Georgia Physicians for Accountable Care to Improve Clinical Outcomes in the Southeast
PR Newswire - Thu May 12, 4:34PM CDT
Evolent Health (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, announced today its partnership with Georgia Physicians for Accountable Care (GPAC). The partnership will guide the development and execution of a value-based care strategy for improving patient health in Georgia.
EVH: 22.76 (-0.04)
Evolent Health Announces First Quarter 2016 Results
PR Newswire - Thu May 12, 3:15PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended March 31, 2016.
EVH: 22.76 (-0.04)
Internet Stocks' Q1 Earnings on May 12: EVH, LTRPA, UPLD
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:44AM CDT
Among the companies slated to report this week, let's see what's ahead for these three Internet stocks, all of which are slated to release their first-quarter 2016 numbers on May 12.
EVH: 22.76 (-0.04), UPLD: 8.97 (+0.05), GOOGL: 814.96 (-0.99), MSFT: 57.43 (-0.39), LTRPA: 21.21 (+0.12), AAPL: 112.71 (-1.91)
Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Thursday, May 12, 2016
PR Newswire - Thu Apr 28, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent" will release its first quarter operating results on Thursday, May 12, 2016 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.
EVH: 22.76 (-0.04)
Evolent Health Launches Identifi 5.0, Enabling Actionable Insights for Extended Care Teams
PR Newswire - Wed Feb 10, 8:00AM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, is pleased to announce the successful launch of IdentifiSM 5.0. Identifi is purpose-built as a provider-led operating platform for health systems entering, managing or growing value-based contracts and provider-sponsored health plans. The latest platform upgrades, including the launch of the Identifi Practice application, bring critical patient insights and a holistic patient view directly to the point of care.
EVH: 22.76 (-0.04)
Evolent Health to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
PR Newswire - Fri Feb 05, 2:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming LEERINK Partners 5th Annual Global Healthcare Conference in New York.
EVH: 22.76 (-0.04)
Passport Health Plan and Evolent Health form Strategic Alliance to create Medicaid Center of Excellence in Louisville
PR Newswire - Tue Feb 02, 8:00AM CST
Passport Health Plan and Evolent Health are pleased to announce the formation of a strategic alliance that will create The Medicaid Center of Excellence.
EVH: 22.76 (-0.04)
Evolent Health to Present at the 34th Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Dec 29, 1:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04)
A Refreshing Outlook - Analyst Notes on Unisys, Central Garden & Pet, Evolent Health and Crawford & Co
ACCESSWIRE - Mon Dec 28, 7:10AM CST
NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Unisys Corp. (NYSE: UIS), Central Garden & Pet Co. (NASDAQ: CENTA), Evolent Health Inc. (NYSE: EVH) and Crawford & Co. (NYSE: CRD.
. Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
EVH: 22.76 (-0.04), CENTA: 24.39 (+0.36), UIS: 9.45 (+0.04), CRD.B: 11.09 (-0.22)
Traders Look to Upside - New Reports on Amkor Technology, A10 Networks, Stemline Therapeutics and Evolent Health
ACCESSWIRE - Thu Dec 24, 6:31AM CST
NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Amkor Technology Inc. (NASDAQ: AMKR), A10 Networks Inc. (NYSE: ATEN), Stemline Therapeutics Inc. (NASDAQ: STML) and Evolent Health Inc. (NYSE: EVH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
AMKR: 9.13 (-0.26), EVH: 22.76 (-0.04), STML: 10.58 (+0.35), ATEN: 10.53 (-0.01)
Business Talent Group Closes Series B Funding led by NextEquity Partners to Accelerate Firm's Leadership in the Fast-Growing Market for Independent Professionals
PR Newswire - Mon Sep 12, 7:00AM CDT
Business Talent Group (BTG), the leading platform for top independent consultants and executives doing project-based work, announced today that it has closed an $8 million Series B funding round led by NextEquity Partners. The round also includes participation from David and Katherine Bradley through the Bradley Family Trust; Ted Meisel, the former CEO of Overture and co-founder of AVIA Health Innovation; and numerous existing investors. NextEquity Managing Director Adam Hopkins will join BTG's board as will Frank Williams, CEO of Evolent Health and former CEO and Chairman of The Advisory Board Company. Ted Meisel and NextEquity Principal Rami Reyes, will join as board observers.
EVH: 22.76 (-0.04)
Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
PR Newswire - Thu Sep 08, 8:59PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health"
, today announced the pricing of a secondary public offering of 7,500,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The shares of Class A common stock are being sold to the public at a price of $22.50 per share. The offering was upsized from the previously announced offering size of 7,000,000 shares of Class A common stock. The underwriters have a 30-day option period to purchase up to 1,125,000 additional shares of Class A common stock from the Investor Stockholders. The offering is expected to close on September 14, 2016, subject to customary closing conditions. JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)
Evolent Health, Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PR Newswire - Tue Sep 06, 3:01PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health"
, today announced the launch of an underwritten secondary public offering of 7,000,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The underwriters have a 30-day option period to purchase up to 1,050,000 additional shares of Class A common stock from the Investor Stockholders. JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)
Evolent Health Partners with St. Luke's Health Partners to Enhance Care Delivery in Idaho
PR Newswire - Thu Aug 04, 3:20PM CDT
Evolent Health, Inc (NYSE: EVH), and St. Luke's Health Partners announced today that they have entered into a definitive agreement for a multi-year operating partnership. The collaboration between the two organizations will guide the development and execution of a value-based care strategy for improving the health of patients across the care delivery network of St. Luke's Health System, the largest locally-owned health system in the state of Idaho.
EVH: 22.76 (-0.04)
Evolent Health Announces Second Quarter 2016 Results
PR Newswire - Thu Aug 04, 3:19PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended June 30, 2016.
EVH: 22.76 (-0.04)
Evolent Health to Participate in Upcoming Investor Conferences
PR Newswire - Thu Jun 02, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent"
, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, Seth Blackley, President and Co-Founder, Nicky McGrane, CFO, and Steve Wigginton, Chief Development Officer, will participate in upcoming investor conferences. EVH: 22.76 (-0.04)
Chasm Partners Places New CEO for Remedy Partners
PRWeb - Thu May 26, 3:06AM CDT
Chasm Partners, a leading retained search firm focused exclusively on health technology and services, announced today the placement of Carolyn Magill as the new CEO of its client, Remedy Partners. Chasm Partners was selected earlier this year to lead the CEO search for Remedy Partners.
EVH: 22.76 (-0.04)
Evolent Health to Host Investor and Analyst Day on May 25, 2016
PR Newswire - Fri May 20, 8:42AM CDT
Evolent Health, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, will host its first Investor and Analyst Day on Wednesday, May 25, 2016 at its headquarters in Arlington, VA.
EVH: 22.76 (-0.04)
Evolent (EVH) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:14AM CDT
Evolent (EVH) reported loss of 24 cents per share, wider than the Zacks Consensus Estimate of a loss of 19 cents.
EVH: 22.76 (-0.04), MDSO: 56.51 (-0.08), QSII: 11.49 (unch), ATHN: 123.83 (-0.79)
Evolent Health Partners with Georgia Physicians for Accountable Care to Improve Clinical Outcomes in the Southeast
PR Newswire - Thu May 12, 4:34PM CDT
Evolent Health (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, announced today its partnership with Georgia Physicians for Accountable Care (GPAC). The partnership will guide the development and execution of a value-based care strategy for improving patient health in Georgia.
EVH: 22.76 (-0.04)
Evolent Health Announces First Quarter 2016 Results
PR Newswire - Thu May 12, 3:15PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended March 31, 2016.
EVH: 22.76 (-0.04)
Internet Stocks' Q1 Earnings on May 12: EVH, LTRPA, UPLD
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:44AM CDT
Among the companies slated to report this week, let's see what's ahead for these three Internet stocks, all of which are slated to release their first-quarter 2016 numbers on May 12.
EVH: 22.76 (-0.04), UPLD: 8.97 (+0.05), GOOGL: 814.96 (-0.99), MSFT: 57.43 (-0.39), LTRPA: 21.21 (+0.12), AAPL: 112.71 (-1.91)
Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Thursday, May 12, 2016
PR Newswire - Thu Apr 28, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent"
will release its first quarter operating results on Thursday, May 12, 2016 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. EVH: 22.76 (-0.04)
Evolent Health Launches Identifi 5.0, Enabling Actionable Insights for Extended Care Teams
PR Newswire - Wed Feb 10, 8:00AM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent"
, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, is pleased to announce the successful launch of IdentifiSM 5.0. Identifi is purpose-built as a provider-led operating platform for health systems entering, managing or growing value-based contracts and provider-sponsored health plans. The latest platform upgrades, including the launch of the Identifi Practice application, bring critical patient insights and a holistic patient view directly to the point of care. EVH: 22.76 (-0.04)
Evolent Health to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
PR Newswire - Fri Feb 05, 2:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent"
, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming LEERINK Partners 5th Annual Global Healthcare Conference in New York. EVH: 22.76 (-0.04)
Passport Health Plan and Evolent Health form Strategic Alliance to create Medicaid Center of Excellence in Louisville
PR Newswire - Tue Feb 02, 8:00AM CST
Passport Health Plan and Evolent Health are pleased to announce the formation of a strategic alliance that will create The Medicaid Center of Excellence.
EVH: 22.76 (-0.04)
Evolent Health to Present at the 34th Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Dec 29, 1:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent"
, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. JPM: 67.25 (-0.14), EVH: 22.76 (-0.04)
A Refreshing Outlook - Analyst Notes on Unisys, Central Garden & Pet, Evolent Health and Crawford & Co
ACCESSWIRE - Mon Dec 28, 7:10AM CST
NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Unisys Corp. (NYSE: UIS), Central Garden & Pet Co. (NASDAQ: CENTA), Evolent Health Inc. (NYSE: EVH) and Crawford & Co. (NYSE: CRD.
. Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis. EVH: 22.76 (-0.04), CENTA: 24.39 (+0.36), UIS: 9.45 (+0.04), CRD.B: 11.09 (-0.22)
Traders Look to Upside - New Reports on Amkor Technology, A10 Networks, Stemline Therapeutics and Evolent Health
ACCESSWIRE - Thu Dec 24, 6:31AM CST
NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Amkor Technology Inc. (NASDAQ: AMKR), A10 Networks Inc. (NYSE: ATEN), Stemline Therapeutics Inc. (NASDAQ: STML) and Evolent Health Inc. (NYSE: EVH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
AMKR: 9.13 (-0.26), EVH: 22.76 (-0.04), STML: 10.58 (+0.35), ATEN: 10.53 (-0.01)
(0)
(0)